Through stimulation of the aryl hydrocarbon receptor (AhR), the IDO/TDO/Kynurenine pathway promotes immune tolerance in the tumor microenvironment via suppression of NK cells and cytotoxic T cells and promotion of regulatory T cells [171] (Fig. 4). Here, TDO2 is linked to neoplasm.